NATO DIANA Human performance and biotechnology Companies

United Kingdom · 2025 cohort

Develops portable sensors for acute radiation syndrome detection to support medical resilience.

France · 2025 cohort

Develops rapid diagnostic systems for point-of-care medical testing in austere environments.

United Kingdom · 2025 cohort

Imperial College London spin-out developing brain- computer interfaces to decode brain signals for pilot and surgical training.

Canada · 2025 cohort

Develops wearable, wireless ultrasound devices for non-invasive cardiac monitoring in field settings.

France · 2025 cohort

Develops pulsed electromagnetic field therapy devices for accelerating physical trauma recovery.

Türkiye · 2025 cohort

Develops advanced medical training simulators for field medic preparation.

France · 2025 cohort

Develops wearable exoskeleton and assistive robotics to enhance soldier physical performance.

United States · 2025 cohort

Develops neurotechnology applications for cognitive enhancement in military contexts.

Canada · 2025 cohort

Develops wearable, portable dialysis technology for life- sustaining care in remote environments.

Netherlands · 2025 cohort

Develops genomic and biological tools for personalised health monitoring and performance optimisation.

United States · 2025 cohort

Develops electronic nose technology for rapid detection of chemical and biological hazards.

Country not publicly verified · 2025 cohort

Develops biosensor and biotechnology platforms for real-time health and environmental monitoring.

United States · 2025 cohort

Develops AI-powered decision support and medical triage tools for emergency and combat casualty care.

Finland · 2026 cohort

Develops biomedical and health monitoring research in support of extreme-environment operations.

Germany · 2026 cohort

Develops robotic exoskeletons to support and augment soldiers in physically demanding missions.

Canada · 2026 cohort

Develops a whole-blood conversion unit converting A, B and AB-type blood into universal blood.

United Kingdom · 2026 cohort

Develops rapid blood diagnostics and point-of-care testing for battlefield medical triage.

France · 2026 cohort

Develops ultrasensitive and ultrafast immunoassays for rapid toxin detection.

Canada · 2026 cohort

Develops a drillless bone-fracture fixation solution for austere surgical environments.

Canada · 2026 cohort

Develops on-edge, multi-diagnostic AI for real-time detection of traumatic torso injuries.

Netherlands · 2026 cohort

Develops wearable systems reducing cognitive load and improving situational awareness.

United Kingdom · 2026 cohort

Develops precision phage therapy for treating battlefield infections resistant to antibiotics.

Germany · 2026 cohort

Develops detection technologies for biological and chemical threat agents.

United States · 2026 cohort

Develops a rugged, head-worn telemedicine device for hands-free use in austere environments.

United Kingdom · 2026 cohort

Develops photodynamic therapeutics and research tools for field wound treatment.

Germany · 2026 cohort

Develops anti-infective solutions for treating drug- resistant bacterial infections in the field.

United Kingdom · 2026 cohort

Develops synthetic platelet products for haemorrhage control in combat casualty care.

United States · 2026 cohort

Develops reliable oxygen delivery solutions as alternatives to blood transfusion in trauma care.